The study goal is to investigate whether administration of oral baclofen forms an adequate
treatment option in the management of acute alcohol withdrawal. The investigators will
compare placebo with doses of baclofen 30 and 60 milligram per day (mg/day) in a randomized
controlled trial including patients receiving symptom triggered diazepam.